BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18545640)

  • 1. Gastric epithelial cell modality and proton pump inhibitor.
    Masaoka T; Suzuki H; Hibi T
    J Clin Biochem Nutr; 2008 May; 42(3):191-6. PubMed ID: 18545640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum gastrin and chromogranin A levels in patients with fundic gland polyps caused by long-term proton-pump inhibition.
    Fossmark R; Jianu CS; Martinsen TC; Qvigstad G; Syversen U; Waldum HL
    Scand J Gastroenterol; 2008 Jan; 43(1):20-4. PubMed ID: 18938772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton Pump Inhibitor-Related Gastric Mucosal Changes.
    Kim GH
    Gut Liver; 2021 Sep; 15(5):646-652. PubMed ID: 32327613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinicopathological characteristics of gastric polyps and the relationship between fundic gland polyps, Helicobacter pylori infection, and proton pump inhibitors.
    Gao W; Huang Y; Lu S; Li C
    Ann Palliat Med; 2021 Feb; 10(2):2108-2114. PubMed ID: 33725768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton Pump Inhibitor Induction of Gastric Cobblestone-like Lesions in the Stomach.
    Takahari K; Haruma K; Ohtani H; Kiyoto S; Watanabe A; Kamada T; Manabe N; Hatano Y
    Intern Med; 2017 Oct; 56(20):2699-2703. PubMed ID: 28924108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GASTRIC FUNDIC GLAND POLYPS: CAN HISTOLOGY BE USEFUL TO PREDICT PROTON PUMP INHIBITORS USE?
    Brito HLF; Barros C; Freire MV; Silva Filho MND; Nascimento TV
    Arq Gastroenterol; 2018; 55(4):380-384. PubMed ID: 30785522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton-pump inhibitor-induced fundic gland polyps with hematemesis.
    Tanaka M; Kataoka H; Yagi T
    Clin J Gastroenterol; 2019 Apr; 12(2):193-195. PubMed ID: 30251013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Gastric Polyps: 15 Years of Proton Pump Inhibitor Therapy.
    Cabrera Charleston M; Oscura Paredes DG; Alfaro Mendez G; Cabrera Tello JM
    Cureus; 2024 May; 16(5):e60814. PubMed ID: 38779437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy.
    Jalving M; Koornstra JJ; Wesseling J; Boezen HM; DE Jong S; Kleibeuker JH
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1341-8. PubMed ID: 17059515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fundic Gland Polyposis Associated with Proton-Pump Inhibitor Use.
    Hamada K; Takeuchi Y; Akasaka T; Iishi H
    Eur J Case Rep Intern Med; 2017; 4(5):000607. PubMed ID: 30755947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review with meta-analysis: fundic gland polyps and proton pump inhibitors.
    Martin FC; Chenevix-Trench G; Yeomans ND
    Aliment Pharmacol Ther; 2016 Nov; 44(9):915-925. PubMed ID: 27634363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological analysis of fundic gland polyps secondary to PPI therapy.
    Fukuda M; Ishigaki H; Sugimoto M; Mukaisho KI; Matsubara A; Ishida H; Moritani S; Itoh Y; Sugihara H; Andoh A; Ogasawara K; Murakami K; Kushima R
    Histopathology; 2019 Oct; 75(4):537-545. PubMed ID: 31087669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemorrhagic polyps formed like fundic gland polyps during long-term proton pump inhibitor administration.
    Takeda T; Asaoka D; Tajima Y; Matsumoto K; Takeda N; Hiromoto T; Okubo S; Saito H; Aoyama T; Shibuya T; Sakamoto N; Hojo M; Osada T; Nagahara A; Yao T; Watanabe S
    Clin J Gastroenterol; 2017 Oct; 10(5):478-484. PubMed ID: 28660530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New-generation proton pump inhibitors: progress in the treatment of peptic acid diseases?].
    de Korwin JD; Ducrotté P; Vallot T
    Presse Med; 2004 Jun; 33(11):746-54. PubMed ID: 15257232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of short-and long-term medical treatment of gastroesophageal reflux disease (GERD).
    Pohle T; Domschke W
    Langenbecks Arch Surg; 2000 Aug; 385(5):317-23. PubMed ID: 11026702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids-What Is the Relationship?
    McCarthy DM
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis.
    Tran-Duy A; Spaetgens B; Hoes AW; de Wit NJ; Stehouwer CD
    Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1706-1719.e5. PubMed ID: 27211501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of proton pump inhibitors and vonoprazan on the development of 'gastric mucosal redness'.
    Shinozaki S; Osawa H; Miura Y; Hayashi Y; Sakamoto H; Yano T; Kawarai Lefor A; Yamamoto H
    Biomed Rep; 2022 Jun; 16(6):51. PubMed ID: 35620314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of proton pump inhibitor use in gastrointestinal polyps.
    Hsu WH; Wu IC; Kuo CH; Su YC; Lu CY; Kuo FC; Jan CM; Wang WM; Wu DC; Yu FJ
    Kaohsiung J Med Sci; 2010 Feb; 26(2):76-83. PubMed ID: 20123595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case-control analysis of fundic gland polyps and proton-pump inhibitors. A pathologist's perspective.
    Velazquez-Dohorn M; López-Durand CF; Candanedo-González F; Araujo-Villalvazo EA; Gamboa-Domínguez A
    Rev Gastroenterol Mex (Engl Ed); 2020; 85(1):42-47. PubMed ID: 31126726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.